Savara Inc Long-Term Debt, Maturity, Year One
Savara Inc (SVRA) had Long-Term Debt, Maturity, Year One of $0 as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-08-11
- 2026-06-30: Long-Term Debt, Maturity, Year One $0.00.
- 2026-03-31: Long-Term Debt, Maturity, Year One $0.00.
- 2025-12-31: Long-Term Debt, Maturity, Year One $0.00.
- 2025-06-30: Long-Term Debt, Maturity, Year One $0.00.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2022-03-31 | $8.33M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $8.33M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $8.33M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.33M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.33M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $2.00M 10-K · filed 2020-03-12 |
| 2016-12-31 | $1.78M 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |